THOMAS RUSSO: Open Payments
NPI 1902804412 · COXSACKIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 40 payments from 12 companies in 2025. Trend: 2023 $668 · 2024 $1,580 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $388 |
| PFIZER INC. | 6 | $110 |
| Novo Nordisk Inc | 6 | $105 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Exact Sciences Corporation | 2 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Abbott Laboratories | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| BETA BIONICS, INC. | 2 | $20 |
Products named: AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Kerendia, PREVNAR 20, ELIQUIS, Rybelsus.
Industry payments across NY — which companies pay providers there.
